Skip to main content
Clinical Trials/NCT03426202
NCT03426202UnknownNot Applicable

The Effect of Modafinil on Neural Processing During the Interference and Feedback Based Learning Task

University of Electronic Science and Technology of China1 site in 1 country60 target enrollmentStarted: January 1, 2018Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Neural processing during the interference processing

Study Overview

Brief Summary

The study aims to examine whether a single dose of modafinil (200mg, p.o.) can affect feedback-based learning and interference processing in healthy male subjects.

Detailed Description

Based on previous animal and human research suggesting a catecholamine-mediated, potentially pro-cognitive, mechanism of action of modafinil, the present study seeks to explore effects of modafinil on feedback-based learning and interference processing in healthy subjects. To this end, the present randomized double-blind, between-subject, placebo-controlled pharmaco-fMRI experiment plans to determine the behavioral and neural effects of a single dose of p.o.modafinil (200mg) versus placebo on validated feedback-based learning and emotional/non-emotional cognitive conflict paradigms. To control for potential effects of pre-medication personality traits as well as effects of modafinil on subjective task performance, subjects will be administered pre-treatment assessing relevant personality traits and post-treatment assessments of meta-cognitive confidence estimation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
18 Years to 30 Years (Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Healthy subjects without past or current psychiatric or neurological disorders
  • •Non-smokers
  • •Right-handedness

Exclusion Criteria

  • •Medical or psychiatric illness
  • •Allergy against medications or general strong allergies
  • •Sleep disorders
  • •High blood pressure, general cardio-vascular alterations
  • •History of head injury
  • •Visual or motor impairments

Arms & Interventions

placebo group

Experimental

a single dose of p.o. placebo (200mg)

Intervention: Placebo Oral Tablet (Drug)

modafinil group

Experimental

a single dose of p.o. modafinil (200mg)

Intervention: Modafinil Oral Tablet (Drug)

Outcomes

Primary Outcomes

Neural processing during the interference processing

Time Frame: 4h after treatment

fMRI BOLD indices of neural processing in interference related brain regions will be compared between the treatment and placebo group.

Neural processing during feedback based learning

Time Frame: 4h after treatment

fMRI BOLD indices of neural processing learning related brain regions will be compared between the treatment and placebo group.

Secondary Outcomes

  • Behavioral interference performance - Response Time(4h after treatment)
  • Behavioral interference performance - Accuracy(4h after treatment)
  • Behavioral learning performance - Accuracy(4h after treatment)
  • Behavioral learning performance - Reaction time(4h after treatment)

Investigators

Sponsor
University of Electronic Science and Technology of China
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Benjamin Becker

Professor

University of Electronic Science and Technology of China

Study Sites (1)

Loading locations...

Similar Trials